Zacks.com on MSN17h
McKesson (MCK) Stock Drops Despite Market Gains: Important Facts to NoteThe latest trading session saw McKesson (MCK) ending at $602.95, denoting a -0.24% adjustment from its last day's close. The stock fell short of the S&P 500, which registered a gain of 0.92% for the ...
Geneos Wealth Management Inc. increased its position in shares of McKesson Co. (NYSE:MCK – Free Report) by 5.6% in the 4th ...
Introduction Cerumen is a natural substance produced in the ear canal to protect the ears from dust, debris, and microorganisms. It also helps ...
KKR & Co. has taken a 12% strategic stake in Henry Schein Inc and will work with the company to improve operations at the ...
Medical Electronic Market To Exceed USD 19.53 Billion By 2032 Due To Healthcare Tech Advancements & Chronic Disease Rise The Medical Electronics Market has rapidly surged, driven by tech advancements ...
Wells Fargo analyst Stephen Baxter maintained a Hold rating on Cencora (COR – Research Report) yesterday and set a price target of $251.00. The ...
Microsoft Research on MSN23h
The value of AI: How Microsoft’s customers and partners are creating differentiated AI solutions to reinvent how they do business todayOrganizational leaders in every industry around the world are evaluating ways AI can unlock opportunities, drive pragmatic ...
The private-equity firm KKR has taken a big stake in the medical- and dental-supply company Henry Schein and plans to work ...
Knight and Helsinn had entered into an exclusive license, distribution and supply agreement for AKYNZEO ® oral/IV (netupitant/palonosetron / fosnetupitant/palonosetron) in Canada, Brazil, Argentina, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback